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Summary 
We have cloned a group of cDNAs representing 
mRNAs that are rapidly induced following adherence 
of human monocytes. One of the induced transcripts 
(MAD-3) encodes a protein of 317 amino acids with one 
domain containing five tandem repeats of the cdclO/ 
ankyrin motif, which is 60% similar (46% identical) to 
the ankyrin repeat region of the precursor of NF-KS/ 
KBFl ~50. The C-terminus has a putative protein ki- 
nase C phosphorylation site. In vitro translated MAD-3 
protein was found to specifically inhibit the DNA- 
binding activity of the p5O/p65 NF-KB complex but not 
that of the p5O/p50 KBFl factor or of other DNA- 
binding proteins. The MAD-3 cDNA encodes an IKE- 
like protein that is likely to be involved in regulation of 
transcriptional responses to NF-KS, including adhe- 
sion-dependent pathways of monocyte activation. 
Introduction 
NF-KB is an important transcription factor originally char- 
acterized as an lgk enhancer binding protein (Sen and 
Baltimore, 1988). In addition, binding sites for NF-KB are 
present in the regulatory regionsof certain cytokine genes, 
the interleukin-2 (IL-2) receptor gene, class I and II histo- 
compatibility antigen genes, an acute phase response 
gene, and several viral enhancers, including HIV-1 (Le- 
nardo and Baltimore, 1989; Shimizu et al., 1990; Lieber- 
mann and Baltimore, 1990; Fan and Maniatis, 1989; Visva- 
nathan and Goodbourn, 1989; Lenardo et al., 1989; 
Btihnlein et al., 1988; Baldwin and Sharp, 1988; Blanar et 
al., 1989; Ron et al., I.&O; Nabel and Baltimore, 1987). 
These sites appear to be critical for appropriate regulated 
or cell type-specific gene expression. Stimulation by a 
number of agents including PMA, IL-18 TNFa, and lipo- 
polysaccharide results in the induction of nuclear NF-KB 
DNA-binding activity (Sen and Baltimore, 1986; Osborn 
et al., 1989; Israel et al., 1989; Lowenthal et al., 1989; 
Shirakawa et al., 1989; Lenardo and Baltimore, 1989). 
NF-KB is a complex of two proteins, ~50 and p65 (Baeuerle 
and Baltimore, 1989). The’CDNA encoding the ~50 DNA- 
binding subunit of NF-KB hasbeen cloned, and the pre- 
dicted protein ‘was shown to be’related to the Drosophila 
dorsal maternal effect gene ‘and to the c-rel proto- 
oncogene product (Ghosh et al., 1990; Kieran et al., 1990; 
Bours et al., 1990; Meyer et al., 199i). Furthermore, it 
appears that the ~50 DNA-binding subunit is processed 
from a 105 kd precursor protein that has six C-terminal 
repeats of the ankyrin consensus sequence (Kieran et al., 
1990; Ghosh et al., 1990). Ankyrins are known to constitute 
a family of proteins that regulate interactions between a 
variety of membrane structures and the cytoskefeton (Lux 
et al., 1990). Proteins bearing multiple repeats of these 
structures are thus highly tikely to be associated with re- 
ceptors and the cytoskeleton. The DNA-binding activity 
KBFl is the homodimar of the NF-KB p50 DNA-binding 
subunit (Kieran et al., 1990). The cloning of the cDNA 
encoding the. ~85 NF-KB subunit has recently been re- 
ported and the predicted protein sequence demonstrates 
homology to c-rel as well (Nolan et al., 1991;. Ruben et al., 
1991). 
In many cells, NF-KB is localized in the cytoplasm where 
it is associated,with a 38 kd inhibitor protein, IKB (Baeuerle 
and Baltimore, 1988a, 1988b; Ghosh and Baltimore, 1999; 
Zabel and Baeuerle. 1990). The ~85 NF-KB subunit a’p- 
pears to be the target of interaction 0f’l~B (Baeuerle and 
Baltimore, 1989; Ghosh and Baltimore, 1990; Urban and 
Baeuerle, 1990; Nolan et al., 1991). Evidence tias been 
presented that phosphorylation of IKB blocks its ability to 
inhibit NF-KB DNA-binding activity, since protein kinase C 
(PKC) and several other kinases activate NF-KB DNA- 
binding activity in vitro (Ghosh and Baltimore, 1990; Shira- 
kawa and Mizel, 1989). 
Adherence of monocytes to plastic results in the rapid 
induction of many known cytokines, including IL-l, TNFa, 
colony stimulating factor-l, and the down-regulation of 
other constitutively expressed receptors and mediators 
including c-fms and lysozyme (Haskill et al., 1988; Eierman 
et al., 1989). We have described the cloning of a series of 
novel cDNA clones from a monocyte library constructed 
from monocytes adhered on plastic for 30 min (Sporn et 
al., 1990; Haskill et al., 1990,199l). We demonstrate here 
that another unique cDNA clone, MAD-3, encodes a protein 
that appears by several criteria to be an IxB-like molecule. 
Results 
We have studied gene expression in monocytes adhering 
to different substrates as models qf mononuclear phago- 
cyte maturation and of inflammation (Haskill et al., 1988; 
Eierman et al., 1989). One gene, MAD-3, is expressed 
early after monocyte adherence to plastic. By Northern 
analysis the transcripts are 1.8 kb in size and 0.04% abun- 
dant in 30 min plastic-adherent monocytes (Sporn et al., 
1990). Adherence resulted in at least an 86fold induction 
and expression was transient: levels returned to baseline 
within 8 hr (data not shown). Inclusion of cycloheximide 
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Figure 1. Nucleotkle and Amino Acid Se- 
quence and Hydrophobic&y Predictions for the 
MAD-3 cDNA 
(A) Nucleic acid and predicted protein se- 
quence of cDNA clone MAD-3. The DNA se 
quence and the amino acid transtatfon pre- 
dicted by the DNA sequence are also shown. 
The 1.6 kb size of the clone is close to that 
predicted from the transcript size on Northern 
analysis. The consensus tyrosine phosphoryla- 
tion site and the pcesible phosphatidyfino- 
sitol-3 kinase binding domain is underfined. the 
predicted PKC pftosphorylation site is over- 
lined, and the three AllTA motifs are under- 
lined and typed in bofd. The ankyrin repeat do 
main (Lux et al., 1990) is typed in bold, and 
individual repeats are overfined and under- 
lined. 
(B) Hydrophilicity/hydrophobicity predictions 
for the proposed MAD-3 protein. The limits of 
the five ankyrfn repeats are overlined and the 
location of individual ones are marked. The pre- 
dicted phosphatidylinositol-3 kinase binding 
domain and the apparent PKC target se 
quences are also overfined. The plot was de- 
rived with the University of Wisconsin GCG pro- 
gram PEPPLOT 
RPSTR 
- 
during adherence enhanced slightly the levels of mRNA, 
demonstrating that MAD-3 is an immediate-early gene in- 
duced by monocyte adherence (data not shown). 
cDNA isolated from the original LgtlO library used to define 
adherence-induced cDNA clones (Sporn et al., 1990). The 
sequence of the MAD-3 cDNA of 1550 bp is shown in 
Figure IA. It extends 94 bp 5’ of a Kozak consensus se- 
quence (Kozak, 1989) for the predicted start of translation. 
Structure of MAD-3 cDNA The 3’ untranslated region contains three ATlTA motifs 
A full-length cDNA of MAD-3 was cloned from a library that usually signal rapid turnover of the mRNA (Caput et 
constructed from RNA pooled from fresh neutrophils and al., 1986; Shaw and Kamen, 1986). A poly(A) tail begins 
collagen-adherent monocytes. The probe was a 350 bp at the end of bp 1550. 
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The predicted poiypeptide specified by the open reading 
frame is composed of 317 amino acids and should encode 
a protein of approximately 34 kd. Secondary structure pre- 
dictions suggest that the protein is arranged in three do- 
mains (Figure 1 B). The N-terminal domain contains a hy- 
drophilic stretch of 72 amino acids, which is marked by a 
consensus sequence (DEEYEQMVK) for tyrosine phos- 
phoryiation and is similar to the potential binding site of 
the phosphatidyiinositoi-3 kinase (amino acids 39-47) 
(Cantley et al., 1991). The C-terminal domain contains two 
regions of interest. One is a consensus sequence for PKC 
phosphoryiation (RPSTR) (amino acids 280-284) (Noiand 
et al., 1989). The other is a region rich in PEST residues 
(amino acids 284-314), which have been associated with 
rapid protein turnover (Rogers et al., 1988). The internal 
domain (amino acids 73-242) consists of five tandem re- 
peats of the ankyrin consensus sequence (Lux et al., 
1990). This region was found to be 80% similar (48% iden- 
tity) to the homologous ankyrin repeat region of the NF-KBI 
KBFl precursor (Ghosh et al., 1990; Kieran et al., 1990). 
The other domains of MAD-3 were dissimilar to NF-KBI 
KBFl . 
MAD-3 Encodes a 36-38 kd Protein with 
Properties of IKB 
The presence of a consensus sequence for PKC phos- 
phorylation, the predicted 34 kd size of the expressed pro- 
tein, and the homology with the precursor of NF-KBIKBF~ 
suggested the possibility that MAD-3 encodes an IxB-like 
protein. To test this hypothesis the full-length MAD3cDNA 
sequence was cloned into the expression plasmid pcDNA 
1 and RNA was transcribed using SP8 RNA polymerase. 
Since the reticuiocyte lysate used for translation contained 
an endogenous NF-KB-like activity (data not shown), the 
iysates were depleted for this activity using a DNA affinity 
matrix specific for NF-KB. These NF-KB-depleted reticulo- 
cyte lysates demonstrated virtually no major histocompati- 
biiity complex (MHC) class I enhancer binding activity (Fig- 
ure 28, lane 5). The reticulocyte lysates were then used to 
Protein was labeled with [“Slmethionine. The mobilities of prestained 
molecular weight markers are shown. 
(6) Gel mobility shift analyzing programmed reticulocyte lysates and 
nuclear extracts of PMA- and PHA-treated Jurkat T cells. For all lanes 
the class I MHC enhancer probe was used. The following protein 
sources were used: nuclear extracts of stimulated Jurkat T cells (lane 
1). Jurkat extracts plus MAD-3 programmed lysates (lane 2. WT), Jur- 
kat extracts plus lysates translated with mRNA from the Accl-deleted 
construct (lane 3, A), Jurkat extracts plus mock-translated reticulocyte 
lysates (lane 4, MT), and mock-translated reticulocyte lysates alone 
(lane 5, MT). The large arrow indicates the mobility of the NF-KB-DNA 
complex, and the small arrow indicates the mobility of the KBFI-DNA 
complex. 
(C) Gel mobilitv shift assay characterizina the nuclear extracts of the 
stimulated Jurkat T cellsThe following protein sources were used: 
extracts of stimulated Jurkat T cells (lanes 1-5) plus either antiserum 
to the ~50 DNA-binding subunit of NF-KB (lane 4, I indicates immune 
antiserum) or preimmune (P) serum (lane 5). The DNA probes are as 
indicated above the figure: MUT (MHC double point mutant probe), 
Igr, and MHC (class I MHC enhancer probe). The large arrow indicates 
the mobility of the NF-&-DNA complex, and the small arrow indicates 
the mobility of the KBFl-DNA complex. 
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Figure 2. In Vitro Transcribed MAD3 mRNA Translates a 36-33 kd 
Protein with Properties of IKB 
(A) 10% SDS-polyacrylamide gel analyzing reticulocyte lysates pro- 
grammed with in vitro transcribed MAD-3 mRNA (lane 1, wr) or with 
MAD-3 mRNA transcribed from an Accl-digested plasmid (lane 2, A). 
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translate either full-length MAD-3 mRNA or mRNA derived 
from an Accl digest of the cDNA or were mock translated. 
Accl cuts the MAD-3 cDNA at the position corresponding 
to amino acid 186 in the fourth ankyrin repeat. The in vitro 
translated products, labeled with [%]methionine, were 
electrophoresed on a 10% SDS-polyacrylamide gel. As 
predicted from the cDNA, the full-length MAD-3 mRNA 
and the mRNA from the Accl-digested plasmid revealed 
approximately 36 and 22 kd proteins (Figure 2A, lanes 1 
and 2). 
The MAD-3 translation products were then tested in a 
gel mobility shift assay for their ability to inhibit NF-ICB 
activity. A class I MHC enhancer sequence (TGGGGATT-  
CCCCA),  previously demonstrated to bind NF-~B(Baldwin 
and Sharp, 1988), was used as a DNA-binding probe. We 
chose to analyze whether NF-KB activity in Jurkat T cells 
stimulated with phytohemagglutinin (PHA) and phorbol 
1Bmyristate 19acetate (PMA) would be inhibited by the 
MAD-3 protein. The induction of NF-KB in these cells has 
been well documented (Nabel and Baltimore, 1987; Bohn- 
lein et al., 1988) and, furthermore, there is an activity with 
properties of KBFl in nuclear extracts of stimulated cells. 
As noted below, the DNA-protein complexes indicated by 
the arrows (Figure 2) appear by various criteria to be 
NF-KB and KBFl. Addition of the MAD-3 programmed ly- 
sates inhibited the DNA-binding activity associated with 
the slower NF-KB-DNA complex (indicated by the large 
arrow, Figure 28, lane 2) in the stimulated Jurkat T nuclear 
extracts and only weakly affected the factor associated 
with the faster moving KBFl -DNA complex (indicated by 
the small arrow, Figure 28, lane 2). Addition of either ly- 
sates programmed with the deleted mRNA or mock- 
translated lysates did not affect DNA-binding activity of 
either complex (Figure 28, lanes 3 and 4). 
To further characterize the DNA-binding activities in the 
nuclear extracts of the PMA- and PHA-stimulated Jurkat 
cells, several assays were performed. We first demon- 
strated that the two activities identified by the arrows are 
specific for the MHC enhancer probe, as they do not inter- 
A B 
act with a double point mutated probe (Figure 2C, lane 1). 
We have previously shown that this mutant probe (TGC- 
GGATTCCCGA) is not bound by NF-KB (Baldwin and 
Sharp, 1988). The factors associated with the slower and 
faster complexes interact equally well with Igw and class 
I MHC enhancer probes (Figure 2C, lanes 2 and 3) consis- 
tent with these activities being NF-KB and KBFl. Finally, 
the two DNA-protein complexes are recognized by anti- 
bodies against the p50 subunit of NF-KB (Figure 2C, lane 
4) but not by preimmune serum (Figure 2C, lane 5). Thus, 
the MAD-3 protein strongly inhibits an authentic NF-KB 
activity from stimulated Jurkat T cells and may inhibit the 
Jurkat KBFl activity very weakly. 
To demonstrate that the observed inhibition is specific 
for the NF-KB activity, we analyzed the effect of the MAD-3 
protein on other characterized DNA-binding proteins (Fig- 
ure 3A). MAD-3 did not inhibit the DNA-binding activity of 
the major late transcription factor (Carthew et al., 1985; 
also known as USF), the Ott-1 factor (Singh et al., 1986) 
or H2TF1, a class I MHC enhancer binding factor (Baldwin 
and Sharp, 1987). We next analyzed whether NF-KB from 
another cell source would be inhibited by the translated 
MAD-3 protein. NF-KB from nuclear extracts of freshly iso- 
lated monocytes was inhibited by the MAD-3 protein, but 
the KBFl activity found in these cells was unaffected (Fig- 
ure 38). Both the NF-KB and KBFl activities in these ex- 
tracts are recognized by antibodies to the ~50 NF-KB sub- 
unit (data not shown). Thus, the MAD-3 protein is highly 
specific for NF-KB from several cell sources and has little 
or no effect on KBFl DNA-binding activity (Figures 28 and 
38). These results are consistent with the observation that 
IKB interacts with the 65 kd subunit of NF-KB (Baeuerle 
and Baltimore, 1989; Ghosh and Baltimore, 1990; Urban 
and Baeuerle, 1990; Nolan et al., 1991) which is absent 
in KBFl (Kieran et al., 1990). We therefore conclude that 
the MAD-3 translation product specifically inhibits NF-KB 
DNA-binding activity and does not inhibit the DNA-binding 
activity of KBFl , major late transcription factor, Ott-1 , or 
HPTFl 
Figure 3. Specificity of Inhibition of DNA- 
Binding Activity by the MAD-3 Protein 
IWTIC: . wr  MT lumc: . MT W (A) Gel mobility shift analyzing various DNA- 
binding activities. The adenovirus major late 
transcription factor (MLTF) and Ott-1 (OCTA) 
MLTW 0 MONW’U’t.~ probes (as indicated) were incubated with nu- 
- clearextractsof stimulated JurkatTcells(lanes 
l-3) plus MAD-3 programmed lysates (lane 2, 
OcrA WT) or plus mock-translated lysates (lane 3, 
1 2 3 MT). The class I MHC enhancer probe was in- 
cubated with a phosphocellulose fraction from 
HeLa cells (lane 1) containing the DNA-binding 
activity H2TFl (Baldwin and Sharp, 1987) plus 
MAD-3 programmed lysates (lane 2. WT) or 
plus mock-translated lysates (lane 3, MT). 
(8) Gel mobility shift analyzing NF-KB in nu- 
clear extracts of monocytes. The class I MHC 
enhancer probe was incubated with nuclear extracts of freshly isolated monocytes (lane 1). Lane 2 included the addition of mock-translated lysates 
(MT) and lane 3 included the addition of MAD-3 translated lysates (WT). The large arrow indicates the mobility of the NF-KB-DNA complex, and 
the small arrow indicates the mobility of the KBFl-DNA complex. 
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Figure 4. Direct Interaction between MAD-3 and NF-KB 
(A) DOC releases NF-KB DNA-binding activity from the MAD-3 inhibi- 
tion. Gel mobility shift using the class I MHC enhancer probe with the 
following binding conditions: DNA affinity-purified NF-KS (lanes 13) 
plus MAD-3 programmed lysates (lanes 2 and 3). Following incubation 
of the purified NF-KS with the MAD-3 programmed extract, DOC was 
added, followed by NP-40 (lane 3). The arrow indicates the mobility of 
the NF-KB-DNA complex. 
(B) Antibodies to NF-KS immunoprecipitate MAD-2 In vitro translated, 
[~Sjmethioninelabeled MAD-2 protein (lane 1) was incubated with 
NF-KS, followed by a no-serum control (lane 2) preimmune serum (P, 
lane 3) or antibodies to NF-KS (I, lane 4). Reactions for lanes 2-4 were 
then added to protein A-Sepharose, and protein was recovered for 
SDS-polyacrylamide gel electrophoresis as described in the Experi- 
mental Procedures. 
Deoxycholate Treatment Dissociates Preformed 
MAP3/NF-KB Complexes 
NF-KB is found in the cytoplasm of many uninduced cells 
where it is bound to IKB, rendering it incapable of binding 
DNA (Baeuerle and Baltimore, 1988a, 1988b). This cyto- 
plasmic form of NF-KB can, however, be liberated from 
IKB by treatment with sodium deoxycholate (DOC),  thus 
making it competent for DNA binding (Baeuerle and Bal- 
timore, 1988a). We first purified NF-KB by DNA affinity 
chromatography to remove any potential endogenous 
NF-KB-IKB complexes. As with the crude nuclear extracts 
of stimulated Jurkat T cells (see Figure 28) the MAD-3 
translation product inhibited this partially purified NF-KB 
(Figure 4A, lane 2). Treatment of the NF-KBIMAD~ reac- 
tion with sodium DOC followed by NP-40 incubation re- 
leased NF-KB DNA-binding activity (Figure 4A, lane 3). 
Thus, the release of NF-KB DNA-binding activity from the 
reaction isderived from NF-KB-MADdcomplexesand not 
from any endogenous NF-KB-IKB in the extract. Since 
NF-KB DNA-binding activity can be recovered from pre- 
formed NF-KBIMAD~ by DOC treatment, we conclude 
that MAD-3 encodes a protein with properties of IKB. 
Antibodies to NF-KB lmmunoprecipitate MAD-3 
To determine if the translated MAD-3 protein directly inter- 
acts with NF-KB, an immunoprecipitation experiment was 
performed. The MAD-3-NF-KB complex was specifically 
immunoprecipitated by antibodies (Kieran et al., 1990) to 
the ~50 DNA-binding subunit of NF-KB (Figure 48, lane 4) 
but not by preimmune serum or by a no-serum control 
(Figure 48, lanes 3 and 2, respectively). These results 
demonstrate that MAD-3 protein interacts directly with the 
NF-KB complex, presumably though the p88 subunit. 
MAD-3 Encodes a Protein with IKElike Activity 
Several characteristics of the predicted amino acid se- 
quence encoded by the MAD-3 cDNA led us to consider 
whether it had properties of IKB. The first was that the 
protein has homology with the ankyrin repeat domain of 
the NF-KBIKBF~ precursor, which is in the portion of the 
precursor that is removed from the DNA-binding subunit 
(Kieran et al., 1990; Ghosh et al., 1990). The second was 
that the predicted (34 kd) and expressed (38-38 kd) molec- 
ular sizes of the protein are quite similar to that (38 kd) of 
partially purified IKB (Ghosh and Baltimore, 1990; Zabel 
and Baeuerle, 1990). A third was that the MAD-3 protein 
has several putative protein kinase consensus target se- 
quences, and it has been demonstrated that phosphory- 
lated IKB will not inhibit the DNA-binding activity of NF-KB 
(Ghosh and Baltimore, 1990; Shirakawa et al., 1989). 
MAD-3 protein that was translated in vitro (see Figure 
2A) specifically inhibited the DNA-binding activity of NF-KB 
from different sources (Figures 28 and 38). These in- 
cluded NF-KB activity induced by PMA and PHA treatment 
of Jurkat T cells and constitutive NF-KB activity found in 
human monocytes. Furthermore, the DNA-binding activity 
of NF-KB induced by lipopolysaccharide and cyclohexi- 
mide treatment of a mouse pre-B cell line, NF-KB induced 
by PMA treatment of HeLa cells, and the endogenous 
NF-KB found in reticulocyte lysates were also inhibited 
by MAD3 protein (data not shown). The specificity of the 
inhibition was demonstrated by the fact that other charac- 
terized DNA-binding activities are not inhibited by MAD-3 
protein (Figure 3A). Furthermore, KBFl DNA-binding ac- 
tivity from freshly isolated monocytes and from Jurkat cells 
is virtually unaffected by MAD-3 protein. Thus, the DNA- 
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binding activity of NF-KB, which is composed of 50 kd and 
65 kd proteins (Baeuerle and Baltimore, 1969), is inhibited 
by the translated MAD-3 protein, whereas the DNA- 
binding activity of KBFl , which is apparently a homodimer 
of the 50 kd subunit (Kieran et al., 1990), is not or is only 
weakly affected (Figures 28 and 38). These results are in 
agreement with previous data that demonstrate that IKB 
inhibits the DNA-binding activity of NF-KB through the 65 
kd subunit (Baeuerle and Baltimore, 1969; Ghosh and Bal- 
timore, 1990; Urban and Baeuerle, 1990; Nolan et al., 
1991). Whether MAD-3 is identical to the IKB that has been 
described awaits purification of that activity and cloning of 
its cDNA. Furthermore, it is entirely possible that there 
are multiple IKB activities, possibly existing in a cell type- 
specific distribution. In fact, two forms of IKB have been 
identified (Zabel and Baeuerle, 1990). In addition, it will be 
important to determine if MAD-3 inhibits the DNA-binding 
activities of other members (Ballard et al., 1990) of the rel 
proto-oncogene family. 
MAD-3 May Integrate Membrane Adhesive 
Interactions with the Cytoskeleton 
and Transcription 
Proteins bearing ankyrin repeats appear to play a promi- 
nent roleincellgrowthanddifferentiation(Luxet al., 1990). 
Erythrocyte ankyrinsfunction as binding sitesand anchors 
for integral membrane proteins, including the Na++K+- 
ATPase and the voltage-dependent Na’ channel, and 
brain ankyrin can bind tubulins and other proteins (dis- 
cussed in Lux et al., 1990). The second domain of MAD-3 
contains five tandem repeats of the ankyrin motif that have 
a high degree of homology to the precursor of the tran- 
scription factor KBFlINF-KB (Kieran et al., 1990; Ghosh 
et al., 1990). This highly conserved motif is found in key 
differentiation-related genes of invertebrates, including 
the nofch (Wharton et al., 1985), /in-72 (Yochem et al., 
1988), fern-l (Spence et al., 1990), and c&-70 proteins 
(Aves et al., 1985). It has been proposed that the structure 
of all these proteins and their manner of expression are 
consistent with their being receptors or adhesive proteins 
involved in intracellular signaling (Lux et al., 1990). The 
ankyrin motif is the postulated site of association between 
notch and an invertebrate version of a G  protein p subunit 
(Hartley et al., 1988). 
We propose that the ankyrin repeats of MAD-3 and the 
NF-KBIKBF~ precursor form the basis for a common ad- 
dress for subcellular localization, bringing the two proteins 
into close proximity. The precise location is still open to 
speculation, but it seems probable from the other known 
functions of human ankyrins that this is likely to be associ- 
ated with cytoskeletal or receptor structures. The known 
induction of numerous cytokine genes by cytochalasin D 
and colchimide-sensitive adhesion events and the rapid 
translocation of PKC induced by adherence (Eierman and 
Haskill, 1991) suggest that transcription may occur through 
a pathway that integrates receptor signaling and induction 
of specific genes through cytoskeletal-bound transcription 
factors. 
MAD-3 May Function as a Negative Regulator 
of Environmental Signals in Inflammatory 
Macrophages and a Feedback Inhibitor 
in Target Tissues 
The widespread usage of NF-KB in transcriptional re- 
sponses to cytokines (Lenardo and Baltimore, 1989) raises 
the concern that cells that both secrete these cytokines 
and can respond to the same factors would require appro- 
priate feedback inhibition. Monocytes and epithelial cells 
have recently been shown to synthesize an IL-l receptor 
antagonist that may serve in part to limit IL-1 respon- 
siveness (Eisenberg et al., 1990; Haskill et al., 1991). The 
IKB inhibitor offers the possibility of a more pleiotropic 
regulator of cytokine responsiveness. The low constitutive 
level of MAD-3 mRNA in monocytes but the high nuclear- 
associated activity of NF-KB in these same cells suggest 
that monocytes in the circulation are primed for rapid 
NF-KB-dependent responses. Adherence leads to trans- 
location of PKC (Eierman and Haskili, 1991), which may 
lead to further NF-KB nuclear localization and signaling. 
However,  we now show that this also results in the parallel 
induction of the MAD-3/l~B gene, which then has the abil- 
ity to down-regulate further responsiveness to mediators 
that transcriptionally activate other genes via NF-KB. The 
rapid induction of the MAD-3 gene by adherence closely 
parallels that of IL-lb (Eierman et al., 1989) and thus pro- 
vides an important potential mechanism for homeostatic 
regulation either through complex formation with NF-KB in 
the cytosol or through displacement of high affinity NF-KB 
bound to DNA (Zabel and Baeuerle, 1990). 
Experimental Procedures 
Isolation of a Full-Length Version of the MAD-3 cDNA 
We have previously reported isolation of a partial MAD-3 cDNA clone, 
which was derived from a lgtl0 cDNA library produced from 30 min 
adhered monocytes (Sporn et al., 1990). Differential screening of this 
library had identified a series of unique clones representing immedi- 
ate-early genes induced by adherence. One of these, MAD-3, was a 
350 bp fragment of a 1.6 kb mRNA. This partial clone was used to 
screen a second library constructed by lnvitrogen in the pcDNA 1 
vector. mRNA was derived from 30 min adhered monocyles and neu- 
trophils. Screening of this library identified several apparently full- 
length clones. One of these was sequenced. 
DNA Sequence Analysis of cDNA Clones 
Chain termination sequencing was carried out with the US6 seque- 
nase procedure employing dlTP to eliminate compressions as neces- 
sary. Primers were synthesized to permit overlapping bidirectional se- 
quencing of the entire cDNA clone. 
Computer Analysis 
All computer analysis and assembly of sequence information were 
carried out with the aid of the University of Wisconsin GCG programs. 
The FASTP program was used to identify the initial homology to an- 
kyrin. Searches employing Wordsearch failed to find similar matches. 
GAP was used to determine the degree of homology between the 
NF-KBIKBF~ protein and the MAD-3 predicted protein sequence de- 
rived from TRANSLATE. 
In Vitro Transcription and Translation of MAD-3 mRNA 
Two micrograms of pcDNA 1 (Invitrogen) containing full-length MAD-3 
cDNA was digested with BamHI, which cuts downstream of the cDNA 
insert, or with Accl. The digests were phenol-chloroform extracted, 
ethanol precipitated, and used to synthesize RNA in a 100 PI reaction 
:rnrr,ediate-Early Gene That Encodes IKB Activity 
for 1 hr at 37OC using SPB RNA polymerase under conditions recom- 
mended by the manufacturer (Boehringer Mannheim). The RNA was 
extracted twice with phenol+?hloroform, ethanol precipitated, and re- 
dissolved in 20 ul of water. Synthesis of RNA wasconfirmed byelectro- 
phoresis of the RNA on agarose gels. Rabbit reticulocyte lysates were 
first depleted of an endogenous NF-&-like DNA-binding activity. This 
was performed by adding 100 ul of lysate to 20 ul of DNA affinity resin 
previously washed with deionized water (see description of preparation 
of the resin below). The binding reaction was performed, with frequent 
mixing, for 10 min at room temperature. The mixture was pelleted by 
brief centrifugation in a microfuge and the supernatant was removed 
for in vitro translation reactions. Four microliters of RNA was used for 
in vitro translation in rabbit reticulocyte lysates following the manufac- 
turer’s (Promega Biotech) recommendations. The [YS]methionine 
labeled products were analyzed on a 10% SDS-polyacrylamide gel 
using the method of Laemmli (1970). The gel was dried and then ex- 
posed for autoradiography. 
Gel Moblllty Shift Assays 
DNA-protein binding reactions were carried out in 10 mM Tris (pH 
7.7) 50 mM NaCI, 0.5 mM EDTA, 1 mM DTT, 2 pg of poly(dl-dC) 
(Pharmacia), and 10% glycerol in a final volume of 20 pl. The reactions 
contained 10 ug of nuclear extracts and/or 1 ul of rabbit reticulocyte 
lysates (either programmed with MAD-3 mRNA or mock translated) 
and 10,000 cpm of end-labeled MHC enhancer binding probe. ~50 
antiserum (0.5 ul) (gift of Alain Israel,, Pasteur Institute) or 0.5 ul of 
preimmune serum was added directly to the binding reaction. The 
reactions were kept at room temperature for 15 min and then loaded 
on a nondenaturing 5% polyacrylamide gel using a TrislglycinelEDTA 
buffer (Baldwin, 1990); they were then electrophoresed for approxi- 
mately 2 hr at 20 mA. The gel was then dried and autoradiographed 
overnight at -7OOC. 
NF-I&-IKE Blndlng and Dlsaoclatlon Reactions 
Nuclear extracts (10 ug) containing NF-KB were reacted with 1 pl 
of MAD-3 programmed lysates or mock-translated lysates under the 
binding conditions described above. The reactions were kept at room 
temperature for 10 min followed by the addition of 2 pg of poly(dldC) 
and 10,000 cpm of radiolabeled DNA probe. The reactions were then 
loaded onto a 5% polyacrylamide Trislglycine/EDTA gel and analyzed 
as described above. For the dissociation reactions, 0.8% sodium DOC 
was added to the binding reactions (minus poly(dldC) and probe) 
followed by 1.2% NP-40. Poly(dldC) and probe were added and incu- 
bated at room temperature for 15 min. These reactions were electro- 
phoresed and analyzed as described above. 
The DNA-binding probes are labeled Hindlll-EcoRI digests of pUC 
plasmids containing oligonucleotides cloned into the polylinker with 
BamHl restriction ends. Sequences are as follows: the class I MHC 
enhancer probe, GGCTGGGGATTCCCCATCT;  the mutant MHC 
probe, GGCTGCGGATTCCCGATCT (Baldwin and Sharp, 1987); the 
major late transcription factor probe, ACCCGGTCACGTGGCCTACA; 
the Ott-1 probe, ATGCAAAT; the Igw probe, CAGAGGGACTTTCC- 
GAGA. 
Nuclear Extracts and DNA Afflnlty Chromatography 
Jurkat T cells were grown in RPM1 1640 medium and 10% fetal calf 
serum. For stimulation of Jurkat T cells, PHA and PMA were added to 
final concentrations of I @ml and 50 @ml, respectively. Monocytes 
were isolated from donors as previously described (Haskill et al., 1988). 
Nuclear extracts were prepared by the method of Swick et al. (1989). 
The DNA affinity resin contained the MHC class I enhancer sequence 
covalently linked to cyanogen bromide-activated Sepharose 4B 
(Sigma). The resin was made and the purification of NF-KB was carried 
out essentially by the method of Kadonaga and Tjian (1986). Nuclear 
extracts of PMA- and PHA-stimulated Jurkat T cells were used for the 
NF-KB purification. Jurkat nuclear extracts were incubated with the 
resin for 20 min, and NF-KB was eluted with a salt gradient. Only 
one round of DNA affinity chromatography was performed. Different 
fractions were tested forthe NF-KB DNA-binding activity by gel mobility 
shift assays, and positive fractions were used for the DCC experiment. 
Immunopreclpltatlon of MAD-3 
The binding reactions between NF-KB and the MAW product were 
carried out as described above. After 10 min, 2.5 ul of antiserum 
against NF-KB (Kieran et al., 1990). preimmune serum, or 1 x binding 
buffer was added to the reactions and allowed to incubate for another 
10 min at room temperature. The reactions were then added to 20 ul 
of protein A-Sepharose beads (Sigma) preequilibrated in 1 x binding 
buffer. After 15 min of frequent mixing, the reactions were briefly spun 
in a microfuge and the supernatants were removed. The beads were 
then washed as described (Springer, 1989). after which they were 
boiled for 5 min in 1 x SDS loading buffer, briefly spun, and the super- 
natants run on a 10% SDS-polyacrylamide gel as described above. 
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